Telomere crisis in leukemia

International Journal of Hematology

Volumn 65, Issue 4, 1997, Pages 355-364

  Ishikawa, Fuyuki ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Chromosome; Leukemia; Telomerase; Telomere

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; ENZYME INHIBITOR; RNA; TELOMERASE;

CANCER GROWTH; CHROMOSOME BREAKAGE; CLINICAL PROTOCOL; CLONE; DICENTRIC CHROMOSOME; DNA REPLICATION; ENZYME ACTIVITY; HUMAN; IONIZING RADIATION; LEUKEMIA; PRIORITY JOURNAL; REVIEW; TELOMERE;

EID: 0031172431     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(97)00575-6     Document Type: Review

References (46)

1. [1] Nowell PC, Hungerford DA. A minute chromosome in human chronic granulocytic leukemia. Science 1960;132:1497.
2. [2] Fialkow PJ, Gartler SM, Yoshida A. Clonal origin of chronic myelocytic leukemia in man. Proc Natl Acad Sci USA 1967;58:1468-1471.
3. [3] Zakian VA. Structure and function of telomeres. Annu Rev Genet 1989;23:579-604.
4. [4] Gall JG. Beginning of the end: origins of the telomere concept. In: Blackburn EH, and Greider CW. (eds). Telomeres. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1995;1-10.
5. [5] McClintock B. The stability of broken ends of chromosomes in Zea mays. Genetics 1941;26:234-282.
6. [6] de Lange T. Telomere dynamics and genome instability in human cancer. In: Blackburn EH. and Greider CW. (eds). Telomeres. Cold Spring Harbor: Cold Spring Harbor Laboratory Press. 1995;265-293.
7. [7] Meyne J, Ratliff RL, Moyzis RK. Conservation of the human telomere sequence (TTAGGG) among vertebrates. Proc Natl Acad Sci USA 1989;86:7049-7053.
8. [8] Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-573.
9. [9] Wright WE, Shay JW. Time, telomeres and tumors: is cellular senescence more than an anticancer mechanism? Trends Cell Biol 1990;5:293-297.
10. [10] Watson JD. Origin of concatemeric T7 DNA. Nature New Biol 1972;239:197-201.
11. [11] Olovnikov AM. A theory of marginotomy. J Theor Biol 1973;41:181-190.
12. [12] Levy MZ, Allsopp RC, Futcher AB, et al. Telomere end-replication problem and cell aging. J Mol Biol 1992;225:951-960.
13. [13] Linger J, Cooper JP, Cech TR. Telomerase and DNA end replication: no longer a lagging strand problem? Science 1995;269:1533-1534.
14. [14] Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-462.
15. [15] Hastie ND, Dempster M, Dunlop MG, et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990;346:866-868.
16. [16] Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992;89:10114-10118.
17. [17] Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mut Res 1991;256:271-282.
18. [18] Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985;43:405-413.
19. [19] Greider CW, Blackburn EH. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 1987;51:887-898.
20. [20] Greider CW, Blackburn EH. A telomeric sequence in the RNA of Tetrahymena telomerase required for repeat synthesis. Nature 1989;337:331-337.
21. [21] Collins K, Kobayashi R, Greider CW. Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. Cell 1995;81:677-686.
22. [22] Shippen-Lentz D, Blackburn E. Functional evidence for an RNA template in telomerase. Science 1990;247:546-552.
23. [23] Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesize TTAGGG repeats. Cell 1989;59:521-529.
24. [24] Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-2015.
25. [25] Harley CB, Villeponteau B. Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 1995;5:249-255.
26. [26] Wilkie AOM, Higgs DR, Rack KA, et al. Stable length polymorphism of up to 260 kb at the tip of the short arm of human chromosome 16. Cell 1991;64:595-606.
27. [27] Tatematsu K, Nakayama J, Danbara M, et al. Oncogene 1996;13:2265-2274.
28. [28] Counter CM, Gupta J, Harley CB, et al. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995;85:2315-2320.
29. [29] Ohyashiki K, Ohyashiki JH, Fujimura T, et al. Telomere shortening in leukemic cells is related to their genetic alterations but not replicative capability. Cancer Genet Cytogenet 1994;78:64-67.
30. [30] Hiyama K, Hirai Y, Koizumi S, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995;155:3711-3715.
31. [31] Igarashi H, Sakaguchi N. Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes. Biochem Biophys Res Commun 1996;219:649-655.
32. [32] Clarkson B, Strife A. Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment. Leukemia 1993;7:1683-1721.
33. [33] McGahon A, Bissonnette R, Schmitt M, et al. BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 1994;83:1179-1187.
34. [34] Bedi A, Zehnbauer BA, Barber JP, et al. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 1994;83:2038-2044.
35. [35] Takauchi K, Tashiro S, Ohtaki M, et al. Telomere reduction of specific chromosome translocation in acute myelocytic leukemia. Jpn J Cancer Res 1994;85:127-130.
36. [36] Broccoli D, Young JW, Lange Td. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995;92:9082-9086.
37. [37] Adamson DJ, King DJ, Haites NE. Significant telomere shortening in childhood leukemia. Cancer Genet Cytogenet 1992;61:204-206.
38. [38] Ohyashiki JH, Ohyashiki K, Fujimura T, et al. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res 1994;54:3557-3560.
39. [39] Nowell PC. The cloncal evolution of tumor cell populations. Science 1976;194:23-28.
40. [40] Newbold RF. Multiple malignant transformation of mammalian cells by carcinogens: induction of immortality as a key events. Carcinogenesis 1985;9:17-28.
41. [41] Fearon ER, Hamilton SR, ans Vogelstein B. Clonal analysis of human colorectal tumors. Science 1987;238:193-197.
42. [42] Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991;51:3075-3079.
43. [43] Greaber TG, Osmanian C, Jacks T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996;379:88-91.
44. [44] Shippey CA, Layton M, Secher-Walker LM. Leukemia characterized by multiple sub-clones with unbalanced translocations involving different telomeric segments. Genes Chrom Cancer 1990;2:14-17.
45. [45] Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer. Cancer Res 1995;55:3258-3262.
46. [46] Nakayma J, Saito M, Nakamura H, et al. TLP1: A gene encoding a protein component of mammalian telomerase is a novel member of WD-repeats family. Cell 1997, in press.